[go: up one dir, main page]

CN112875665B - Hydroxyapatite microspheres for injection filling preparation and preparation method thereof - Google Patents

Hydroxyapatite microspheres for injection filling preparation and preparation method thereof Download PDF

Info

Publication number
CN112875665B
CN112875665B CN202110174978.XA CN202110174978A CN112875665B CN 112875665 B CN112875665 B CN 112875665B CN 202110174978 A CN202110174978 A CN 202110174978A CN 112875665 B CN112875665 B CN 112875665B
Authority
CN
China
Prior art keywords
hydroxyapatite
microspheres
preparation
slurry
primary product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202110174978.XA
Other languages
Chinese (zh)
Other versions
CN112875665A (en
Inventor
黄卫民
于卓辰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangdong Zhanmei Biopharmaceutical Technology Co ltd
Original Assignee
Jilin University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jilin University filed Critical Jilin University
Priority to CN202110174978.XA priority Critical patent/CN112875665B/en
Publication of CN112875665A publication Critical patent/CN112875665A/en
Application granted granted Critical
Publication of CN112875665B publication Critical patent/CN112875665B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01BNON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B25/00Phosphorus; Compounds thereof
    • C01B25/16Oxyacids of phosphorus; Salts thereof
    • C01B25/26Phosphates
    • C01B25/32Phosphates of magnesium, calcium, strontium, or barium
    • C01B25/322Preparation by neutralisation of orthophosphoric acid
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01BNON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B25/00Phosphorus; Compounds thereof
    • C01B25/16Oxyacids of phosphorus; Salts thereof
    • C01B25/26Phosphates
    • C01B25/32Phosphates of magnesium, calcium, strontium, or barium
    • C01B25/325Preparation by double decomposition
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01PINDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2004/00Particle morphology
    • C01P2004/01Particle morphology depicted by an image
    • C01P2004/03Particle morphology depicted by an image obtained by SEM
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01PINDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2004/00Particle morphology
    • C01P2004/30Particle morphology extending in three dimensions
    • C01P2004/32Spheres
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01PINDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2004/00Particle morphology
    • C01P2004/60Particles characterised by their size
    • C01P2004/61Micrometer sized, i.e. from 1-100 micrometer

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Materials For Medical Uses (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)

Abstract

本发明涉及用于注射填充制剂的羟基磷灰石微球及其制备方法。所述制备方法包括:步骤1:将钙源、磷源分别配制成钙源溶液和磷源溶液并混合,向其中加入支持电解质,调节所得到的混合溶液的pH为微酸性,然后进行电化学沉积,得到针状亚微米/纳米级羟基磷灰石初级产物;步骤2:将所述羟基磷灰石初级产物进行研磨粉碎,然后配制成料浆;步骤3:将所述料浆进行喷雾干燥,得到羟基磷灰石微球粗品;步骤4:将所述羟基磷灰石微球粗品进行高温煅烧;步骤5:将煅烧后的羟基磷灰石微球粗品进行筛分,得到所述羟基磷灰石微球。本发明的制备方法显著提高了生产效率。所制得的羟基磷灰石微球具有所需的粒径分布和高球形度。

Figure 202110174978

The present invention relates to hydroxyapatite microspheres for injection filling preparations and a preparation method thereof. The preparation method includes: step 1: respectively preparing calcium source solution and phosphorus source solution into calcium source solution and phosphorus source solution and mixing, adding supporting electrolyte to them, adjusting the pH of the obtained mixed solution to be slightly acidic, and then carrying out electrochemical deposition to obtain a needle-shaped submicron/nano-scale hydroxyapatite primary product; step 2: grinding and pulverizing the hydroxyapatite primary product, and then preparing a slurry; step 3: spray-drying the slurry to obtain crude hydroxyapatite microspheres; step 4: calcining the crude hydroxyapatite microspheres at high temperature; step 5: sieving the calcined crude hydroxyapatite microspheres to obtain the hydroxyapatite microspheres limestone microspheres. The preparation method of the present invention significantly improves the production efficiency. The prepared hydroxyapatite microspheres have the desired particle size distribution and high sphericity.

Figure 202110174978

Description

用于注射填充制剂的羟基磷灰石微球及其制备方法Hydroxyapatite microspheres for injection filling preparations and preparation method thereof

技术领域technical field

本发明涉及化学、化学工程与工艺、材料学及生物医学交叉技术,具体地,涉及一种用于注射填充制剂的羟基磷灰石微球及其制备方法,其中通过电化学沉积法制得羟基磷灰石初级产物,然后再制备得到羟基磷灰石微球。The present invention relates to chemistry, chemical engineering and technology, materials science and biomedical interdisciplinary technology, in particular, to a hydroxyapatite microsphere used for injection filling preparations and a preparation method thereof, wherein the hydroxyapatite microspheres are prepared by electrochemical deposition The primary product of limestone is then prepared to obtain hydroxyapatite microspheres.

背景技术Background technique

羟基磷灰石(HAP,Ca10(OH)2(PO4)6),又名羟基磷酸钙,是人及其他动物骨骼的主要无机组成部分。由化学方法直接制备的羟基磷灰石具有与人体骨骼相似的结构和功能,因此广泛应用于生物材料、药学及医学领域,例如药物缓释、血清蛋白分离等领域。特别地,羟基磷灰石常用于自体骨的修复、口腔医学的牙种植体涂层及医美整形等。Hydroxyapatite (HAP, Ca 10 (OH) 2 (PO 4 ) 6 ), also known as calcium hydroxyphosphate, is the main inorganic component of human and other animal bones. Hydroxyapatite directly prepared by chemical methods has a structure and function similar to that of human bone, so it is widely used in the fields of biomaterials, pharmacy and medicine, such as drug sustained release, serum protein separation and other fields. In particular, hydroxyapatite is often used in the restoration of autogenous bone, the coating of dental implants in stomatology, and medical plastic surgery.

通常使用微米级粒径的羟基磷灰石作为软组织损伤的修复材料和结构支撑材料,例如用于制备注射填充制剂。如果羟基磷灰石颗粒的粒径过小,就容易发生羟基磷灰石颗粒从注射部位迁移到其他部位的问题。如果粒径过大,则会使复配成凝胶的聚集物堵塞注射器。因此,优选羟基磷灰石的粒径为25~45μm。Micron-sized hydroxyapatite is commonly used as a repair material and structural support material for soft tissue injuries, for example for the preparation of injectable filling preparations. If the particle size of the hydroxyapatite particles is too small, the problem of the migration of the hydroxyapatite particles from the injection site to other sites easily occurs. If the particle size is too large, aggregates that reconstitute into a gel can clog the syringe. Therefore, the particle diameter of hydroxyapatite is preferably 25 to 45 μm.

此外,如果羟基磷灰石是不规则的非球形结构,就会容易造成人体内的炎症和积液。因此,要求羟基磷灰石的球形度尽量高。In addition, if hydroxyapatite has an irregular non-spherical structure, it will easily cause inflammation and fluid accumulation in the human body. Therefore, the sphericity of hydroxyapatite is required to be as high as possible.

目前,制备具有特定粒径分布、球形度高的羟基磷灰石微球,成为重要的研究对象。At present, the preparation of hydroxyapatite microspheres with specific particle size distribution and high sphericity has become an important research object.

制备羟基磷灰石微球的方法通常包括:首先制备亚微米/纳米级羟基磷灰石初级产物,然后将羟基磷灰石初级产物进行造粒(如喷雾干燥、微波处理、乳液溶剂挥发处理等)、高温煅烧、筛分,从而得到羟基磷灰石微球。The method for preparing hydroxyapatite microspheres usually includes: firstly preparing the primary product of submicron/nanometer hydroxyapatite, and then granulating the primary product of hydroxyapatite (such as spray drying, microwave treatment, emulsion solvent volatilization treatment, etc. ), calcined at high temperature, and sieved to obtain hydroxyapatite microspheres.

一般通过湿化学沉淀法制备亚微米/纳米级羟基磷灰石初级产物。然而,通过湿化学沉淀法得到的初始沉淀物包含磷酸三钙、磷酸八钙等杂质,需要24-120h的时间陈化,才能达到所需的羟基磷灰石初级产物纯度。也就是说,这种方法需要的陈化时间长,且溶液pH过高,不利于连续生产和环境保护。此外,所制备的羟基磷灰石初级产物一般在溶液中为絮状沉淀物,形状不规则,这不利于实现后期的羟基磷灰石的球形度要求。Submicron/nanoscale hydroxyapatite primary products are generally prepared by wet chemical precipitation. However, the initial precipitate obtained by wet chemical precipitation contains impurities such as tricalcium phosphate and octacalcium phosphate, and requires 24-120 hours of aging to achieve the required purity of the primary product of hydroxyapatite. That is to say, the aging time required by this method is long, and the pH of the solution is too high, which is unfavorable for continuous production and environmental protection. In addition, the prepared primary product of hydroxyapatite is generally a flocculent precipitate in the solution with an irregular shape, which is not conducive to achieving the sphericity requirement of the later stage hydroxyapatite.

因此,需要一种生产效率改进的制备羟基磷灰石微球的新方法。此外,需要所制得的羟基磷灰石微球具有粒径优化、球形度高等性能。Therefore, there is a need for a new method of preparing hydroxyapatite microspheres with improved production efficiency. In addition, the prepared hydroxyapatite microspheres are required to have properties such as optimized particle size and high sphericity.

发明内容Contents of the invention

技术问题technical problem

本发明的一个目的是,提供一种用于注射填充制剂的羟基磷灰石微球的制备方法,本发明的制备方法通过采用电化学沉积法,无需长时间陈化就能快速大量制得羟基磷灰石初级产物,并且后续制得的羟基磷灰石微球具有所需的粒径分布和高球形度。由此,显著提高了羟基磷灰石微球的生产效率。此外,制备羟基磷灰石初级产物所需的pH降低,降低了环境污染,并减少了对容器的腐蚀。One object of the present invention is to provide a method for preparing hydroxyapatite microspheres used for injection filling preparations. The preparation method of the present invention can quickly produce a large amount of hydroxyl apatite microspheres without long-term aging The primary product of apatite, and the subsequently prepared hydroxyapatite microspheres have the desired particle size distribution and high sphericity. Thus, the production efficiency of hydroxyapatite microspheres is significantly improved. In addition, the pH required for the production of primary hydroxyapatite products is lowered, reducing environmental pollution and reducing corrosion to containers.

本发明的另一个目的是,提供一种用于注射填充制剂的羟基磷灰石微球,所述羟基磷灰石微球具有所需的粒径分布和高球形度。Another object of the present invention is to provide hydroxyapatite microspheres for injectable filling formulations, which have desired particle size distribution and high sphericity.

技术方案Technical solutions

根据本发明的一个方面,提供一种用于注射填充制剂的羟基磷灰石微球的制备方法,其中所述制备方法包括:According to one aspect of the present invention, there is provided a method for preparing hydroxyapatite microspheres for injection filling preparations, wherein the preparation method comprises:

步骤1:将钙源、磷源分别配制成钙源溶液和磷源溶液并混合,向其中加入支持电解质,调节所得到的混合溶液的pH为微酸性,然后进行电化学沉积,得到针状亚微米/纳米级羟基磷灰石初级产物;Step 1: Calcium source and phosphorus source are formulated into calcium source solution and phosphorus source solution respectively and mixed, adding supporting electrolyte to it, adjusting the pH of the obtained mixed solution to be slightly acidic, and then performing electrochemical deposition to obtain acicular sub Micro/nano hydroxyapatite primary product;

步骤2:将所述羟基磷灰石初级产物进行研磨粉碎,然后配制成料浆;Step 2: Grinding and pulverizing the primary product of hydroxyapatite, and then preparing a slurry;

步骤3:将所述料浆进行喷雾干燥,得到羟基磷灰石微球粗品;Step 3: spray drying the slurry to obtain crude hydroxyapatite microspheres;

步骤4:将所述羟基磷灰石微球粗品进行高温煅烧;Step 4: Calcining the crude hydroxyapatite microspheres at high temperature;

步骤5:将煅烧后的羟基磷灰石微球粗品进行筛分,得到所述羟基磷灰石微球。Step 5: Sieve the calcined crude hydroxyapatite microspheres to obtain the hydroxyapatite microspheres.

在一个实施方案中,在步骤1中,所述钙源为氢氧化钙、硝酸钙、氯化钙中的任一种或它们的混合物,In one embodiment, in step 1, the calcium source is any one of calcium hydroxide, calcium nitrate, calcium chloride or a mixture thereof,

所述磷源为磷酸、磷酸氢二铵、磷酸二氢铵中的任一种或它们的混合物,The phosphorus source is any one of phosphoric acid, diammonium hydrogen phosphate, ammonium dihydrogen phosphate or a mixture thereof,

所述支持电解质为硝酸钠、硝酸钾、硫酸钾中的任一种或它们的混合物。The supporting electrolyte is any one of sodium nitrate, potassium nitrate, potassium sulfate or a mixture thereof.

在一个实施方案中,在步骤1中,所述混合溶液的pH被调至4.0-5.5,使所述混合溶液的温度保持恒定,且为25-70℃,以及In one embodiment, in step 1, the pH of the mixed solution is adjusted to 4.0-5.5, and the temperature of the mixed solution is kept constant at 25-70° C., and

通过搅拌将所述钙源溶液和磷源溶液混合,搅拌速率为100-500r/min,搅拌过程一直持续至电化学沉积结束。The calcium source solution and the phosphorus source solution are mixed by stirring at a stirring rate of 100-500 r/min, and the stirring process is continued until the end of the electrochemical deposition.

在一个实施方案中,在步骤1中,使用电解槽进行电化学沉积,并使用两电极体系或三电极体系,In one embodiment, in step 1, an electrolytic cell is used for electrochemical deposition, and a two-electrode system or a three-electrode system is used,

其中电流密度为0.5-4mA/cm2,电化学沉积的时间为0.5-3h。Wherein the current density is 0.5-4mA/cm 2 , and the electrochemical deposition time is 0.5-3h.

在一个实施方案中,在步骤2中,In one embodiment, in step 2,

将研磨粉碎后的羟基磷灰石初级产物与超纯水、助剂混合,配制成质量分数为20-40wt%的料浆,mixing the ground and pulverized hydroxyapatite primary product with ultrapure water and additives to prepare a slurry with a mass fraction of 20-40wt%,

所述助剂包含选自润湿剂、乳化剂、粘结剂和造孔剂中的一种或多种,The auxiliary agent comprises one or more selected from wetting agents, emulsifiers, binders and pore-forming agents,

所述润湿剂为选自吐温、草酸钠、阳离子聚电解质中的一种或多种,The wetting agent is one or more selected from Tween, sodium oxalate, cationic polyelectrolyte,

所述乳化剂为选自明胶,聚乳酸、聚酰胺、吐温中的一种或多种,The emulsifier is one or more selected from gelatin, polylactic acid, polyamide, Tween,

所述粘结剂为选自聚乙二醇、聚乙烯醇中的一种或多种,The binder is one or more selected from polyethylene glycol, polyvinyl alcohol,

所述造孔剂为选自碳粉、聚乙二醇中的一种或多种,The pore-forming agent is one or more selected from carbon powder, polyethylene glycol,

所述润湿剂、乳化剂、粘结剂和造孔剂各自的质量为所述料浆质量的1-5%。The respective mass of the wetting agent, emulsifier, binder and pore-forming agent is 1-5% of the mass of the slurry.

在一个实施方案中,在步骤3中,喷雾温度为125-500℃,In one embodiment, in step 3, the spray temperature is 125-500°C,

进料速度为10-20ml/min,The feed rate is 10-20ml/min,

喷嘴直径为0.5-1.4mm。The nozzle diameter is 0.5-1.4mm.

在一个实施方案中,在步骤4中,使用高温马弗炉或旋转管式炉进行所述高温煅烧,煅烧温度为800-1400℃。In one embodiment, in step 4, the high-temperature calcination is performed using a high-temperature muffle furnace or a rotary tube furnace, and the calcination temperature is 800-1400° C.

在一个实施方案中,在步骤5中,使用手动分级筛或振动分级筛进行筛分,筛孔目数为180目~1000目。In one embodiment, in step 5, a manual grading sieve or a vibrating grading sieve is used for sieving, and the mesh size of the sieve is 180 mesh to 1000 mesh.

根据本发明的另一方面,提供一种用于注射填充制剂的羟基磷灰石微球,其采用上述制备方法制成,其中所述羟基磷灰石微球的粒径分布范围为14~85μm,球形度为75~95%。According to another aspect of the present invention, there is provided a kind of hydroxyapatite microspheres for injection filling preparation, which is prepared by the above preparation method, wherein the particle size distribution range of the hydroxyapatite microspheres is 14-85 μm , The sphericity is 75-95%.

在一个实施方案中,所述羟基磷灰石微球的粒径分布范围为25~45μm。In one embodiment, the particle size distribution range of the hydroxyapatite microspheres is 25-45 μm.

有益效果Beneficial effect

与首先通过湿化学沉淀法制备羟基磷灰石初级产物、然后制备羟基磷灰石微球的现有技术相比,本发明通过电化学沉积法快速制备针状亚微米/纳米级羟基磷灰石初级产物,然后配制成料浆,接着进行喷雾干燥、高温煅烧、筛分,得到羟基磷灰石微球。Compared with the prior art of firstly preparing the primary product of hydroxyapatite by wet chemical precipitation, and then preparing hydroxyapatite microspheres, the present invention rapidly prepares acicular submicron/nano-sized hydroxyapatite by electrochemical deposition The primary product is then formulated into a slurry, followed by spray drying, high-temperature calcination, and sieving to obtain hydroxyapatite microspheres.

与湿化学沉淀法相比,本发明的电化学沉积法无需陈化,在非常短的时间内即可制备相同质量的高纯度的羟基磷灰石初级产物,这显著提高了整体生产效率。此外,本发明的电化学沉积法所使用的pH更接近中性,对环境更友好。Compared with the wet chemical precipitation method, the electrochemical deposition method of the present invention does not need to be aged, and the same quality high-purity hydroxyapatite primary product can be prepared in a very short time, which significantly improves the overall production efficiency. In addition, the pH used in the electrochemical deposition method of the present invention is closer to neutral and more friendly to the environment.

另外,通过本发明的电化学沉积法所制备的羟基磷灰石初级产物为亚微米级/纳米级针状晶体,纯度高,晶体结构规则,可以使后续制备的羟基磷灰石微球具有更高的球形度,并能够满足定制化的粒径分布需求。In addition, the primary product of hydroxyapatite prepared by the electrochemical deposition method of the present invention is submicron/nano-sized needle-like crystals with high purity and regular crystal structure, which can make the hydroxyapatite microspheres prepared subsequently have more High sphericity, and can meet customized particle size distribution requirements.

附图说明Description of drawings

本说明书的附图显示了本发明的优选实施方案,并且与上述的发明内容一起用于进一步阐明本发明的技术理念。本发明不应被解释为限于附图中所述的内容。The accompanying drawings of this specification show preferred embodiments of the present invention, and are used together with the above-mentioned summary of the invention to further clarify the technical concept of the present invention. The present invention should not be construed as being limited to what is depicted in the drawings.

图1为根据实施例1的步骤1制备的亚微米/纳米级羟基磷酸石初级产物的扫描电镜图(30,000倍)。FIG. 1 is a scanning electron micrograph (30,000 times) of the primary product of submicron/nano-scale hydroxyphosphate prepared according to step 1 of Example 1.

图2为根据实施例1制备的羟基磷灰石微球的扫描电镜图(1,000倍)。2 is a scanning electron micrograph (1,000 times) of the hydroxyapatite microspheres prepared according to Example 1.

图3为根据实施例2制备的羟基磷灰石微球的扫描电镜图(1,000倍)。3 is a scanning electron micrograph (1,000 times) of the hydroxyapatite microspheres prepared according to Example 2.

图4为根据比较例1制备的羟基磷灰石微球的扫描电镜图(1,000倍)。FIG. 4 is a scanning electron micrograph (1,000 times) of the hydroxyapatite microspheres prepared according to Comparative Example 1. FIG.

具体实施方式Detailed ways

在下文中,将参考附图对本发明进行详细描述。在本说明书和权利要求书中使用的术语或词汇不应被限制性地解释为普通或字典的定义,并且应当在发明人可以适当定义术语的概念从而以最好的可能方式来描述发明的原则的基础上解释为与本发明的技术思想相对应的含义和概念。Hereinafter, the present invention will be described in detail with reference to the accompanying drawings. The terms or words used in this specification and claims should not be construed restrictively as common or dictionary definitions, and should be used when the inventor can properly define the concepts of the terms so as to describe the principles of the invention in the best possible way The meaning and concept corresponding to the technical thought of the present invention are interpreted on the basis of the present invention.

除非另有说明,否则本文中所使用的“%”是指重量%。此外,在现有技术中公知的工艺和组分将省略其详细说明。As used herein, "%" means % by weight unless otherwise specified. In addition, detailed descriptions of processes and components known in the art will be omitted.

1.用于注射填充制剂的羟基磷灰石微球的制备方法1. Preparation of Hydroxyapatite Microspheres for Injectable Filling Formulations

根据本发明的一个方面,提供一种用于注射填充制剂的羟基磷灰石微球的制备方法,所述制备方法包括如下步骤。According to one aspect of the present invention, there is provided a method for preparing hydroxyapatite microspheres for injection filling preparations, the preparation method comprising the following steps.

步骤1:羟基磷灰石初级产物的制备Step 1: Preparation of hydroxyapatite primary product

将钙源、磷源分别配制成钙源溶液和磷源溶液并混合,向其中加入支持电解质,调节所得到的混合溶液的pH为微酸性,然后进行电化学沉积,得到针状亚微米/纳米级羟基磷灰石初级产物。Calcium source and phosphorus source are respectively prepared into calcium source solution and phosphorus source solution and mixed, adding supporting electrolyte to it, adjusting the pH of the resulting mixed solution to be slightly acidic, and then performing electrochemical deposition to obtain needle-shaped submicron/nano grade hydroxyapatite primary product.

所述钙源可以例如是氢氧化钙、硝酸钙、氯化钙中的任一种或它们的混合物,优选硝酸钙。The calcium source can be, for example, any one of calcium hydroxide, calcium nitrate, calcium chloride or a mixture thereof, preferably calcium nitrate.

所述磷源可以例如是磷酸、磷酸氢二铵、磷酸二氢铵中的任一种或它们的混合物,优选磷酸二氢铵。The phosphorus source can be, for example, any one of phosphoric acid, diammonium hydrogen phosphate, ammonium dihydrogen phosphate or a mixture thereof, preferably ammonium dihydrogen phosphate.

所述支持电解质可以例如是硝酸钠、硝酸钾、硫酸钾中的任一种或它们的混合物,优选硝酸钠。The supporting electrolyte can be, for example, any one of sodium nitrate, potassium nitrate, potassium sulfate or a mixture thereof, preferably sodium nitrate.

所述钙源和磷源用于在电解液中提供钙离子和磷酸根离子,由此在进行电化学沉积时,阴极区局部氢氧根浓度增大,在阴极区产生羟基磷灰石的沉淀物。The calcium source and phosphorus source are used to provide calcium ions and phosphate ions in the electrolyte, so that when electrochemical deposition is performed, the local hydroxide concentration in the cathode area increases, and the precipitation of hydroxyapatite occurs in the cathode area things.

所述支持电解质用于在不发生副反应的前提下,增强溶液的导电率。The supporting electrolyte is used to enhance the conductivity of the solution without causing side reactions.

可以使用硝酸、磷酸、氨水等来调节所述混合溶液的pH,可以将其调节至微酸性,例如pH 4.0-5.5。微酸性的pH用于防止在pH大于6.5的区间生成不必要的沉淀副产物,但pH过低易引起强烈的析氢副反应,以及抑制羟基磷灰石的生成。Nitric acid, phosphoric acid, ammonia water, etc. can be used to adjust the pH of the mixed solution, which can be adjusted to slightly acidic, such as pH 4.0-5.5. The slightly acidic pH is used to prevent unnecessary precipitation by-products in the pH range greater than 6.5, but too low a pH can easily cause strong hydrogen evolution side reactions and inhibit the formation of hydroxyapatite.

通过水浴使所述溶液的温度保持恒定,例如可以为25-70℃,优选30-65℃,更优选60℃。当所述温度过低时,会影响电沉积步骤产品生成速率。当所述温度过高时,虽然会增大沉积速率,但会在一定程度上影响羟基磷灰石的溶解度、溶液的pH以及造成安全隐患。The temperature of the solution is kept constant by a water bath, such as 25-70°C, preferably 30-65°C, more preferably 60°C. When the temperature is too low, the rate of product formation in the electrodeposition step will be affected. When the temperature is too high, although the deposition rate will be increased, it will affect the solubility of hydroxyapatite, the pH of the solution and cause safety hazards to a certain extent.

在一个实施方案中,将钙源溶液和磷源溶液在电解槽中在搅拌的情况下进行混合,搅拌速率可以为100-500r/min。当搅拌速率过低时,电极表面生成的羟基磷灰石不易脱落;当搅拌速率过高时,由析氢反应所致的传质电流被促进,副反应增强,且易发生溶液飞溅。搅拌过程可以一直持续至电化学沉积结束。In one embodiment, the calcium source solution and the phosphorus source solution are mixed in the electrolytic cell under stirring, and the stirring rate may be 100-500 r/min. When the stirring rate is too low, the hydroxyapatite formed on the electrode surface is not easy to fall off; when the stirring rate is too high, the mass transfer current caused by the hydrogen evolution reaction is promoted, the side reaction is enhanced, and solution splashing is prone to occur. The stirring process can continue until the end of electrochemical deposition.

在电化学沉积工艺中,可以使用电解槽进行电化学沉积,并可以使用两电极体系或三电极体系。阳极、阴极材料可以为本领域公知的常用电极。In the electrochemical deposition process, an electrolytic cell may be used for electrochemical deposition, and a two-electrode system or a three-electrode system may be used. Anode and cathode materials can be common electrodes known in the art.

例如,在所述两电极体系中,阳极可以为铂片、钛片或DSA,阴极可以为不锈钢片、钛片、钛网或钛基二氧化钛电极。其中,钛网的比表面积较大,能够沉积更多的羟基磷灰石,因此优选用作阴极。For example, in the two-electrode system, the anode can be platinum sheet, titanium sheet or DSA, and the cathode can be stainless steel sheet, titanium sheet, titanium mesh or titanium-based titanium dioxide electrode. Among them, titanium mesh has a larger specific surface area and can deposit more hydroxyapatite, so it is preferably used as a cathode.

在所述三电极体系中,阳极和阴极可以分别与上述相同,参比电极可以为饱和甘汞电极。In the three-electrode system, the anode and the cathode can be the same as above, and the reference electrode can be a saturated calomel electrode.

电化学沉积的电流密度可以为0.5-4mA/cm2。当电流密度过高时,会发生严重的析氢副反应,极大地降低了电流效率;当电流密度过低时,会使得电沉积步骤速率缓慢,降低生产效率。The current density of the electrochemical deposition can be 0.5-4 mA/cm 2 . When the current density is too high, serious hydrogen evolution side reactions will occur, which greatly reduces the current efficiency; when the current density is too low, the electrodeposition step rate will be slow and the production efficiency will be reduced.

电化学沉积的时间可以为0.5-3h,优选1-3h,更优选2-2.5h。当所述时间过短时,则产物总量不足;当所述时间过长时,会导致溶液pH变化显著,造成不必要的磷酸钙杂质沉淀生成。The time of electrochemical deposition can be 0.5-3h, preferably 1-3h, more preferably 2-2.5h. When the time is too short, the total amount of the product will be insufficient; when the time is too long, the pH of the solution will change significantly, resulting in unnecessary calcium phosphate impurity precipitation.

通过电化学沉积可以得到固体沉积物,其为针状亚微米/纳米级羟基磷灰石初级产物,呈粉体状。可以将其进一步过滤、洗涤、干燥,用于后续操作。The solid deposit can be obtained by electrochemical deposition, which is the primary product of acicular submicron/nanoscale hydroxyapatite in the form of powder. It can be further filtered, washed and dried for subsequent operations.

步骤2:料浆配制Step 2: Slurry preparation

将步骤(1)所得的羟基磷灰石初级产物进行研磨粉碎,使其具有较好的流动性,然后配制成料浆。The primary product of hydroxyapatite obtained in step (1) is ground and pulverized to make it have better fluidity, and then prepared into a slurry.

可以使用本领域常用的设备如研钵、球磨机等进行研磨粉碎。Grinding and pulverization can be carried out using equipment commonly used in this field, such as a mortar, a ball mill, and the like.

可以使用超纯水、去离子水等溶剂,并通过施加强搅拌来得到料浆。所得料浆通常可以为羟基磷灰石初级产物的20-40wt%的悬浊液。当所述浓度过高时,会导致料浆无法经喷雾干燥成球;当浓度过低时,则会使得喷雾干燥后的粒径过小。A solvent such as ultrapure water, deionized water, etc. may be used, and a slurry may be obtained by applying strong stirring. The resulting slurry may typically be a 20-40 wt% suspension of hydroxyapatite primary product. When the concentration is too high, the slurry cannot be spray-dried into balls; when the concentration is too low, the particle size after spray-drying will be too small.

基于料浆的总质量,可以在料浆中添加质量分数1-5%的助剂。所述助剂可以例如是润湿剂、粘结剂、造孔剂、乳化剂。Based on the total mass of the slurry, 1-5% of additives can be added to the slurry. The auxiliaries can be, for example, wetting agents, binders, pore formers, emulsifiers.

所述润湿剂可以例如是吐温、草酸钠、阳离子聚电解质,优选草酸钠。所述润湿剂用于增强羟基磷灰石初级产物与水之间的润湿作用,使得其他助剂与羟基磷灰石初级产物能够更好地混合。The wetting agent may eg be Tween, sodium oxalate, a cationic polyelectrolyte, preferably sodium oxalate. The wetting agent is used to enhance the wetting effect between the primary product of hydroxyapatite and water, so that other additives can be better mixed with the primary product of hydroxyapatite.

所述粘结剂可以例如是聚乙二醇、聚乙烯醇,优选聚乙二醇。所述粘结剂用于增大喷雾干燥的成球率和微球的球形度。The binder may for example be polyethylene glycol, polyvinyl alcohol, preferably polyethylene glycol. The binder is used to increase the spheroidization rate of spray drying and the sphericity of microspheres.

所述造孔剂可以例如是碳粉、聚乙二醇,优选聚乙二醇。在后续煅烧过程中,造孔剂可以生成气态产物以扩散逸出,从而调控微球的孔隙率。The pore forming agent can be, for example, carbon powder, polyethylene glycol, preferably polyethylene glycol. In the subsequent calcination process, the pore former can generate gaseous products to diffuse and escape, thereby regulating the porosity of the microspheres.

所述乳化剂可以例如是明胶,聚乳酸、聚酰胺、吐温中,优选明胶、聚乳酸。所述乳化剂用于改善浊液中的表面张力,使之形成均匀稳定的分散系。The emulsifier can be, for example, gelatin, polylactic acid, polyamide, Tween, preferably gelatin, polylactic acid. The emulsifier is used to improve the surface tension in the turbid liquid to form a uniform and stable dispersion system.

步骤3:喷雾干燥Step 3: Spray drying

将所述料浆进行喷雾干燥以进行造粒,从而得到羟基磷灰石微球粗品。The slurry is spray-dried for granulation, so as to obtain crude hydroxyapatite microspheres.

可以使用常规的喷雾干燥器进行喷雾干燥。喷雾温度可以为125-500℃,优选200-300℃。当温度过低时,瞬间成核速度降低,成核数量减少,所得微粒粒径增大。当温度过高时,易发生颗粒团聚,这样颗粒粒径反而增大。Spray drying can be carried out using conventional spray dryers. The spraying temperature may be 125-500°C, preferably 200-300°C. When the temperature is too low, the instantaneous nucleation speed decreases, the number of nucleation decreases, and the particle size of the obtained particles increases. When the temperature is too high, the particles are prone to agglomeration, so that the particle size increases instead.

料浆的进料速度可以为10-20ml/min。当进料速率过低时,产量降低,产品粒径偏小。当进料速率过高时,未干燥液体数量增加,粒径偏大。The feed rate of the slurry can be 10-20ml/min. When the feed rate is too low, the output decreases and the particle size of the product is too small. When the feed rate is too high, the amount of undried liquid increases and the particle size becomes larger.

喷嘴直径可以为0.5-1.4mm。当喷嘴出口直径过大时,所得粒径偏小,后续容易发生羟基磷灰石颗粒从注射部位迁移到其他部位的问题。当喷嘴出口直径过大时,所得粒径偏大,会降低复配后凝胶的填充率,并且会延长体内降解时间。The nozzle diameter can be 0.5-1.4mm. When the diameter of the nozzle outlet is too large, the obtained particle size is too small, and the subsequent migration of hydroxyapatite particles from the injection site to other parts is easy to occur. When the nozzle outlet diameter is too large, the obtained particle size is too large, which will reduce the filling rate of the gel after compounding and prolong the degradation time in vivo.

步骤4:高温煅烧Step 4: High temperature calcination

将步骤3所得的羟基磷灰石微球粗品进行高温煅烧。可以使用高温马弗炉或旋转管式炉进行所述高温煅烧。Calcining the crude hydroxyapatite microspheres obtained in step 3 at a high temperature. The high temperature calcination may be performed using a high temperature muffle furnace or a rotary tube furnace.

高温煅烧的温度可以是800-1400℃,优选900~1100℃,其目的是在保证羟基磷灰石不分解的前提下,增强材料的陶瓷化程度。如果温度过低,则无法增强陶瓷化程度;如果温度过高,则会导致羟基磷灰石分解。The temperature of the high-temperature calcination can be 800-1400°C, preferably 900-1100°C, the purpose of which is to enhance the degree of ceramicization of the material on the premise of ensuring that the hydroxyapatite does not decompose. If the temperature is too low, the degree of ceramization cannot be enhanced; if the temperature is too high, it will cause the decomposition of hydroxyapatite.

高温煅烧的时间可以是0.5-2h,以得到性质稳定的羟基磷灰石微球。如果时间过短,则陶瓷化不完全;如果时间过长,则导致生产成本过度增加。The high-temperature calcination time can be 0.5-2h, so as to obtain stable hydroxyapatite microspheres. If the time is too short, ceramization will not be complete; if the time is too long, the production cost will be excessively increased.

步骤5:筛分Step 5: Sieving

将步骤4所得的煅烧后的羟基磷灰石微球粗品进行筛分。可以使用手工筛或振动分级筛进行所述筛分。The calcined crude hydroxyapatite microspheres obtained in step 4 are sieved. The sieving can be performed using a hand sieve or a vibrating classifying sieve.

筛网目数可以是180-1000目。当目数为1000目时,对应粒径约为14μm,其可以筛掉粒径过小的微球或未成球的羟基磷灰石碎屑。当目数为180目时,对应粒径约为85μm,其目的是筛去产品中少量粒径过大的微球或未成球的结块。The screen mesh can be 180-1000 mesh. When the mesh number is 1000 mesh, the corresponding particle size is about 14 μm, which can screen out microspheres with too small particle size or unspherical hydroxyapatite debris. When the mesh number is 180 mesh, the corresponding particle size is about 85 μm. The purpose is to sieve out a small amount of microspheres with too large particle size or agglomerates without balls in the product.

优选地,可以使用目数为325目和550目的筛网进行筛分,以得到粒径分布为25-45μm的羟基磷灰石微球,用于注射填充制剂的配制。Preferably, sieves with 325 mesh and 550 mesh can be used to sieve to obtain hydroxyapatite microspheres with a particle size distribution of 25-45 μm, which are used for the preparation of injection filling preparations.

2.用于注射填充制剂的羟基磷灰石微球2. Hydroxyapatite Microspheres for Injectable Filler Formulations

根据本发明的另一个方面,提供一种用于注射填充制剂的羟基磷灰石微球,其采用上述制备方法制成,其中所述羟基磷灰石微球的粒径分布范围为14~85μm,优选25~45μm。此外,所述羟基磷灰石微球的球形度为75~95%。According to another aspect of the present invention, there is provided a kind of hydroxyapatite microspheres for injection filling preparation, which is prepared by the above preparation method, wherein the particle size distribution range of the hydroxyapatite microspheres is 14-85 μm , preferably 25 to 45 μm. In addition, the sphericity of the hydroxyapatite microspheres is 75-95%.

可以使用本领域常用的设备(例如,粒径分析仪或扫描电子显微镜)来测量羟基磷灰石微球的粒径。The particle size of the hydroxyapatite microspheres can be measured using equipment commonly used in the art (eg, particle size analyzer or scanning electron microscope).

可以使用本领域常用的设备和方法来测量羟基磷灰石微球的球形度。例如,使用扫描电子显微镜与相应的图像处理软件,通过分别测量微球的平均表面积和平均周长,通过下式计算:The sphericity of hydroxyapatite microspheres can be measured using equipment and methods commonly used in the art. For example, using a scanning electron microscope and corresponding image processing software, by measuring the average surface area and the average perimeter of the microspheres respectively, it is calculated by the following formula:

Figure BDA0002940378850000091
Figure BDA0002940378850000091

式中,S为球形度(%);A为由软件测量的微球平均表面积(mm2),C为由软件测量的微球平均周长(mm)。In the formula, S is the sphericity (%); A is the average surface area of the microspheres (mm 2 ) measured by the software, and C is the average circumference of the microspheres (mm) measured by the software.

本发明的羟基磷灰石微球能够充分满足定制化的粒径分布需求,并具有高球形度的特点。The hydroxyapatite microspheres of the present invention can fully meet the requirements of customized particle size distribution, and have the characteristics of high sphericity.

实施例Example

下文中,将参考实施例对本发明进行详细描述,以具体描述本发明。然而,本发明的实施例可以修改为各种其他形式并且本发明的范围不应被解释为限于下面描述的实施例。提供本发明的实施例以向本领域普通技术人员更完整地描述本发明。Hereinafter, the present invention will be described in detail with reference to Examples to specifically describe the present invention. However, the embodiments of the present invention may be modified into various other forms and the scope of the present invention should not be construed as being limited to the embodiments described below. The embodiments of the present invention are provided so as to more fully describe the present invention to those skilled in the art.

下列实施例中的实验方法如果未注明具体条件,通常是本领域的常规条件或按照制造厂商建议的条件;所使用的原料和设备,如无特殊说明,均为可从常规市场等商业途径得到的原料和设备。If the experimental methods in the following examples do not indicate specific conditions, they are usually the conventional conditions in this field or the conditions suggested by the manufacturer; the raw materials and equipment used, if no special instructions, are available from commercial channels such as the conventional market Raw materials and equipment obtained.

实施例1Example 1

通过如下步骤来制备用于注射填充制剂的羟基磷灰石微球。Hydroxyapatite microspheres for injectable fill formulations were prepared as follows.

步骤1:羟基磷灰石初级产物的制备Step 1: Preparation of hydroxyapatite primary product

配制0.5M的硝酸钙溶液(作为钙源)以及0.3M的磷酸氢二铵溶液(作为磷源)各50ml。Prepare 50 ml each of 0.5 M calcium nitrate solution (as calcium source) and 0.3 M diammonium hydrogen phosphate solution (as phosphorus source).

将50ml硝酸钙溶液置于电解槽中,然后在200r/min的转速进行搅拌的情况下将磷酸氢二铵溶液以10ml/min的速度滴入所述硝酸钙溶液中。接着加入一定量的硝酸钠固体(作为支持电解质)使得硝酸钠的浓度为0.1M。然后,使用硝酸和氨水调节pH为4.5。接着,通过水浴将电解槽及其中溶液的温度保持为60℃50ml of calcium nitrate solution was placed in the electrolytic cell, and then the diammonium hydrogen phosphate solution was dropped into the calcium nitrate solution at a speed of 10ml/min under the condition of stirring at a rotating speed of 200r/min. Then add a certain amount of solid sodium nitrate (as a supporting electrolyte) so that the concentration of sodium nitrate is 0.1M. Then, the pH was adjusted to 4.5 using nitric acid and ammonia water. Next, the temperature of the electrolytic cell and the solution therein is maintained at 60°C by a water bath

接着,进行电化学沉积。所述电化学沉积为恒电流沉积,电流密度为2mA/cm2,沉积时间为2.5h。所述电化学沉积采用两电极体系,选用15mm*15mm的铂片作为阳极,选用五片串联的15mm*15mm的钛网作为阴极。Next, electrochemical deposition is performed. The electrochemical deposition is a constant current deposition with a current density of 2 mA/cm 2 and a deposition time of 2.5 h. The electrochemical deposition adopts a two-electrode system, a 15mm*15mm platinum sheet is used as the anode, and five 15mm*15mm titanium meshes connected in series are used as the cathode.

电化学沉积后,在钛网上形成针状羟基磷灰石沉积层,溶液中亦存在少量脱落的羟基磷灰石。对钛网进行刮料操作,并将溶液中的羟基磷灰石过滤。合并二者,然后用每次20ml的超纯水洗涤三次。所得固体置于60℃烘箱中干燥2h,称量得到针状亚微米/纳米级羟基磷灰石初级产物12g。After electrochemical deposition, a needle-shaped hydroxyapatite deposition layer is formed on the titanium mesh, and a small amount of detached hydroxyapatite also exists in the solution. The titanium mesh is scraped and the hydroxyapatite in the solution is filtered. The two were combined, and then washed three times with 20 ml of ultrapure water each time. The obtained solid was dried in an oven at 60° C. for 2 hours, and 12 g of needle-shaped submicron/nano-sized hydroxyapatite primary products were obtained by weighing.

步骤2:料浆配制Step 2: Slurry preparation

将所得针状亚微米/纳米级羟基磷灰石初级产物用研钵研磨粉碎。在烧杯中加入12g经研磨的羟基磷灰石初级产物,28g超纯水,并施加强搅拌,得到质量分数为30wt%的羟基磷灰石料浆,其为悬浊液形式。The obtained acicular submicron/nanoscale hydroxyapatite primary product was pulverized with a mortar. Add 12g of ground hydroxyapatite primary product and 28g of ultrapure water into a beaker, and apply strong stirring to obtain a hydroxyapatite slurry with a mass fraction of 30wt%, which is in the form of a suspension.

步骤3:喷雾干燥Step 3: Spray drying

使用喷雾干燥器将所述羟基磷灰石料浆进行喷雾干燥造粒,喷雾温度为200℃,进料速度为10ml/min,喷嘴直径为0.7mm。得到羟基磷灰石微球粗品。The hydroxyapatite slurry was spray-dried and granulated using a spray dryer, with a spray temperature of 200° C., a feed rate of 10 ml/min, and a nozzle diameter of 0.7 mm. The crude product of hydroxyapatite microspheres was obtained.

步骤4:高温煅烧Step 4: High temperature calcination

将所述羟基磷灰石微球粗品进行高温煅烧,煅烧过程在旋转管式炉中进行,煅烧温度为1100℃,持续60min。The crude hydroxyapatite microspheres were calcined at a high temperature, and the calcining process was carried out in a rotary tube furnace at a calcining temperature of 1100° C. for 60 min.

步骤5:筛分Step 5: Sieving

将煅烧后的羟基磷灰石微球粗品用325目与500目的筛网进行分级过筛,得到粒径分布为25-45μm的羟基磷灰石微球。The calcined crude hydroxyapatite microspheres are classified and screened with 325-mesh and 500-mesh sieves to obtain hydroxyapatite microspheres with a particle size distribution of 25-45 μm.

实施例2Example 2

通过如下步骤来制备用于注射填充制剂的羟基磷灰石微球。Hydroxyapatite microspheres for injectable fill formulations were prepared as follows.

步骤1:羟基磷灰石初级产物的制备Step 1: Preparation of hydroxyapatite primary product

与实施例1的步骤1相同。Same as Step 1 of Example 1.

步骤2:料浆配制Step 2: Slurry preparation

将所得针状亚微米/纳米级羟基磷灰石初级产物用研钵研磨粉碎。在烧杯中加入12g羟基磷灰石初级产物,28g超纯水,并施加强搅拌,得到质量分数为30wt%的羟基磷灰石悬浊液。The obtained acicular submicron/nanoscale hydroxyapatite primary product was pulverized with a mortar. Add 12g of hydroxyapatite primary product and 28g of ultrapure water into a beaker, and apply strong stirring to obtain a hydroxyapatite suspension with a mass fraction of 30wt%.

将该悬浊液用水浴加热至60℃,加入相当于该悬浊液质量1wt%的润湿剂草酸钠,以及相当于该悬浊液质量1wt%的粘结剂聚乙二醇。搅拌均匀后,得到羟基磷灰石料浆。The suspension was heated to 60° C. with a water bath, and a wetting agent sodium oxalate corresponding to 1 wt % of the suspension mass, and a binder polyethylene glycol corresponding to 1 wt % of the suspension mass were added. After uniform stirring, the hydroxyapatite slurry is obtained.

步骤3~5Step 3~5

与实施例1的步骤3~5相同。Same as Steps 3-5 of Example 1.

比较例1Comparative example 1

步骤1:羟基磷灰石初级产物的制备Step 1: Preparation of hydroxyapatite primary product

通过湿化学沉淀法制备羟基磷灰石初级产物。具体地,将0.5M硝酸钙与0.3M磷酸二氢铵各50mL混合均匀,并调节pH为10.5,在水浴60℃下搅拌1h。然后于37℃陈化120h,得到絮状沉淀物。与实施例1类似,将其进行过滤、洗涤、干燥,得到羟基磷灰石初级产物12g。Hydroxyapatite primary product was prepared by wet chemical precipitation. Specifically, 50 mL of 0.5 M calcium nitrate and 0.3 M ammonium dihydrogen phosphate were mixed uniformly, and the pH was adjusted to 10.5, and stirred in a water bath at 60° C. for 1 h. Then aged at 37°C for 120h to obtain a flocculent precipitate. Similar to Example 1, it was filtered, washed, and dried to obtain 12 g of the primary product of hydroxyapatite.

步骤2~5Step 2~5

与实施例1的步骤2~5相同。Same as Steps 2-5 of Example 1.

实验例1羟基磷灰石初级产物和羟基磷灰石微球的表面形态观察Experimental example 1 Observation of the surface morphology of the primary product of hydroxyapatite and hydroxyapatite microspheres

将实施例1的步骤1所得的针状亚微米/纳米级羟基磷灰石初级产物用扫描电子显微镜进行表面形态观察,其结果显示于图1。从图1可以看出,所得的羟基磷灰石初级产物形态很规则,为针状晶体,这有利于在后期制备球形度、力学性能等方面改善的微球。The surface morphology of the acicular submicron/nanoscale hydroxyapatite primary product obtained in step 1 of Example 1 was observed with a scanning electron microscope, and the results are shown in FIG. 1 . It can be seen from Figure 1 that the obtained primary product of hydroxyapatite has a regular shape and is needle-like crystals, which is conducive to the preparation of microspheres with improved sphericity and mechanical properties in the later stage.

将实施例1、实施例2和比较例1所得的羟基磷灰石微球分别用扫描电子显微镜进行表面形态观察,分别得到图2、图3和图4。从图2~4可以看出,实施例1、实施例2和比较例1均得到粒径分布为25-45μm的羟基磷灰石微球。The surface morphology of the hydroxyapatite microspheres obtained in Example 1, Example 2 and Comparative Example 1 was observed with a scanning electron microscope, and Figures 2, 3 and 4 were obtained respectively. It can be seen from Figures 2 to 4 that in Example 1, Example 2 and Comparative Example 1, hydroxyapatite microspheres with a particle size distribution of 25-45 μm were obtained.

实验例2羟基磷灰石微球的球形度测量Experimental Example 2 Sphericity Measurement of Hydroxyapatite Microspheres

使用Media Cybernetics公司的image-pro plus软件(版本号6.0.0.260forWindows 2000/XP Professional)对实施例1、实施例2和比较例1所得的羟基磷灰石微球分别进行平均周长和平均面积的测量,并使用如下公式计算球形度:Use the image-pro plus software (version number 6.0.0.260forWindows 2000/XP Professional) of Media Cybernetics company to carry out average circumference and average area respectively to the hydroxyapatite microsphere of embodiment 1, embodiment 2 and comparative example 1 gain and calculate the sphericity using the following formula:

Figure BDA0002940378850000131
Figure BDA0002940378850000131

式中,S为球形度(%);A为由软件测量的微球平均表面积(mm2),C为由软件测量的微球平均周长(mm)。结果如下表1所示。In the formula, S is the sphericity (%); A is the average surface area of the microspheres (mm 2 ) measured by the software, and C is the average circumference of the microspheres (mm) measured by the software. The results are shown in Table 1 below.

表1Table 1

微球的球形度(%)Sphericity of microspheres (%) 实施例1Example 1 82.482.4 实施例2Example 2 85.085.0 比较例comparative example 67.367.3

从表1可以看出,在球形度方面,实施例1的微球明显优于比较例1的微球,因此实施例1的微球更适合用于制备注射填充制剂。由此确认了,本发明的通过电化学沉积制备的针状羟基磷灰石初级产物能够提高最终所得羟基磷灰石微球的球形度。It can be seen from Table 1 that in terms of sphericity, the microspheres of Example 1 are significantly better than the microspheres of Comparative Example 1, so the microspheres of Example 1 are more suitable for preparing injection filling preparations. It was thus confirmed that the acicular hydroxyapatite primary product prepared by electrochemical deposition of the present invention can improve the sphericity of the final hydroxyapatite microspheres.

此外,在球形度方面,实施例2的微球优于实施例1的微球。由此可以看出,通过在步骤2中添加助剂来配制料浆,可以提高最终所得微球的球形度。In addition, the microspheres of Example 2 are superior to the microspheres of Example 1 in terms of sphericity. It can be seen that by adding additives in step 2 to prepare the slurry, the sphericity of the final microspheres can be improved.

实验例3生产效率的比较Comparison of Experimental Example 3 Production Efficiency

将实施例1的步骤1中形成羟基磷灰石沉积物的时间和比较例1的步骤1中形成羟基磷灰石沉淀物的时间总结为如下表2。The time for forming hydroxyapatite deposits in step 1 of Example 1 and the time for forming hydroxyapatite deposits in step 1 of comparative example 1 are summarized in Table 2 below.

表2Table 2

Figure BDA0002940378850000141
Figure BDA0002940378850000141

从上表2可以看出,实施例1的步骤1中形成羟基磷灰石沉积物的时间明显少比较例1的步骤1中形成羟基磷灰石沉淀物的时间。由此确认了,实施例1的生产效率显著高于比较例1。It can be seen from the above Table 2 that the time for forming hydroxyapatite deposits in step 1 of Example 1 is significantly shorter than the time for forming hydroxyapatite deposits in step 1 of Comparative Example 1. From this, it was confirmed that the production efficiency of Example 1 was significantly higher than that of Comparative Example 1.

虽然为了说明目的公开了本发明的优选实施方案,但本领域技术人员会理解,在不背离权利要求书公开的发明范围和精神的情况下,可以对上述优选实施方案进行各种修改、添加和替代。Although preferred embodiments of the present invention have been disclosed for illustrative purposes, those skilled in the art will appreciate that various modifications, additions and substitute.

Claims (10)

1. A method for preparing hydroxyapatite microspheres for injection filling formulations, wherein the method comprises:
step 1: respectively preparing a calcium source solution and a phosphorus source solution from a calcium source and a phosphorus source, mixing, adding a supporting electrolyte, adjusting the pH value of the obtained mixed solution to 4.0-5.5, and then carrying out electrochemical deposition to obtain a needle-shaped submicron/nanoscale hydroxyapatite primary product;
step 2: grinding and crushing the primary product of the hydroxyapatite, and preparing into slurry;
and step 3: spray drying the slurry to obtain a hydroxyapatite microsphere crude product;
and 4, step 4: calcining the coarse hydroxyapatite microsphere product at high temperature;
and 5: sieving the calcined hydroxyapatite microsphere crude product to obtain the hydroxyapatite microsphere,
wherein the particle size distribution range of the hydroxyapatite microspheres is 14-85 μm, and the sphericity is 75-95%.
2. The preparation method according to claim 1, wherein in step 1, the calcium source is any one of calcium hydroxide, calcium nitrate, calcium chloride or a mixture thereof,
the phosphorus source is any one of phosphoric acid, diammonium hydrogen phosphate and ammonium dihydrogen phosphate or a mixture thereof,
the supporting electrolyte is any one of sodium nitrate, potassium nitrate and potassium sulfate or a mixture of the sodium nitrate, the potassium nitrate and the potassium sulfate.
3. The production method according to claim 1, wherein in step 1,
the temperature of the mixed solution is kept constant and is 25-70 ℃, and
and mixing the calcium source solution and the phosphorus source solution by stirring, wherein the stirring speed is 100-500r/min, and the stirring process is continued until the electrochemical deposition is finished.
4. The production method according to claim 1, wherein in step 1, electrochemical deposition is performed using an electrolytic cell and a two-electrode system or a three-electrode system is used,
wherein the current density is 0.5-4mA/cm2The time of electrochemical deposition is 0.5-3h.
5. The production method according to claim 1, wherein in step 2,
mixing the ground hydroxyapatite primary product with ultrapure water and an auxiliary agent to prepare slurry with the mass fraction of 20-40wt%,
the auxiliary agent comprises one or more selected from a wetting agent, an emulsifier, a binder and a pore-forming agent,
the wetting agent is one or more selected from tween, sodium oxalate and cationic polyelectrolyte,
the emulsifier is one or more selected from gelatin, polylactic acid, polyamide and tween,
the binder is one or more selected from polyethylene glycol and polyvinyl alcohol,
the pore-forming agent is one or more selected from carbon powder and polyethylene glycol,
the mass of the wetting agent, the emulsifying agent, the bonding agent and the pore-forming agent is 1-5% of the mass of the slurry.
6. The preparation process according to claim 1, wherein in step 3, the spraying temperature is 125 to 500 ℃,
the feeding speed is 10-20ml/min,
the diameter of the nozzle is 0.5-1.4mm.
7. The production method according to claim 1, wherein in step 4, the high-temperature calcination is performed using a high-temperature muffle furnace or a rotary tube furnace, and the calcination temperature is 800 to 1400 ℃.
8. The method according to claim 1, wherein in step 5, the screening is performed using a manual classifying screen or a vibration classifying screen, and the number of the screen holes is 180 to 1000.
9. Hydroxyapatite microspheres for injectable filling preparations, prepared by the preparation method according to any one of claims 1 to 8.
10. The hydroxyapatite microspheres according to claim 9, wherein said hydroxyapatite microspheres have a particle size distribution ranging from 25 to 45 μ ι η.
CN202110174978.XA 2021-02-07 2021-02-07 Hydroxyapatite microspheres for injection filling preparation and preparation method thereof Active CN112875665B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110174978.XA CN112875665B (en) 2021-02-07 2021-02-07 Hydroxyapatite microspheres for injection filling preparation and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110174978.XA CN112875665B (en) 2021-02-07 2021-02-07 Hydroxyapatite microspheres for injection filling preparation and preparation method thereof

Publications (2)

Publication Number Publication Date
CN112875665A CN112875665A (en) 2021-06-01
CN112875665B true CN112875665B (en) 2022-11-01

Family

ID=76056243

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110174978.XA Active CN112875665B (en) 2021-02-07 2021-02-07 Hydroxyapatite microspheres for injection filling preparation and preparation method thereof

Country Status (1)

Country Link
CN (1) CN112875665B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113526477B (en) * 2021-06-28 2023-07-21 西安理工大学 A preparation method for transforming hydroxyapatite nanospheres into microrods
CN115477535A (en) * 2022-09-09 2022-12-16 晞华生物科技(上海)有限公司 Ceramic hydroxyapatite for chromatography and preparation method and application thereof
CN118697940B (en) * 2024-05-31 2024-12-24 江苏益通生物科技有限公司 A kind of implant filling material of hydroxyapatite composite microsphere and preparation method thereof

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1903706A (en) * 2006-08-09 2007-01-31 山东大学 Preparation method of hydroxy phosephorite hollow microball
WO2007084858A2 (en) * 2006-01-12 2007-07-26 Rutgers, The State University Biomimetic hydroxyapatite synthesis
CN101643929A (en) * 2009-08-31 2010-02-10 郑州大学 Pulse electrodeposition preparation method of hydroxyapatite coating on surface of pure magnesium or magnesium alloy
WO2010055231A2 (en) * 2008-11-13 2010-05-20 Universite De Reims Champagne-Ardenne Process for the electrodeposition of calcium-phosphorus coatings onto metallic substrates, coatings obtained and implantable materials comprising such coatings
CN102061499A (en) * 2010-12-02 2011-05-18 上海师范大学 Method for preparing multihole hydroxyapatite/polyurethane composite material by electrochemical deposition
CN102908669A (en) * 2012-09-17 2013-02-06 西北工业大学 Preparation method of carbon foam/hydroxyapatite composite coating
CN108969802A (en) * 2018-07-19 2018-12-11 浙江大学 A kind of double induction hydroxyapatite silk fibroin composite membrane coating preparation methods with rush osteogenesis function
CN112121227A (en) * 2020-08-15 2020-12-25 吉林大学 Preparation method of medical composite coating of strontium titanate/strontium hydroxyapatite on titanium metal surface

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0627025B2 (en) * 1991-02-07 1994-04-13 呉羽化学工業株式会社 Hydroxyapatite filter cake dried product
US6045683A (en) * 1997-12-01 2000-04-04 University Of Alabama In Huntsville Modified brushite surface coating, process therefor, and low temperature conversion to hydroxyapatite
US7998219B2 (en) * 2005-01-04 2011-08-16 Rutgers, The State University Of New Jersey Hydroxyapatite with controllable size and morphology
CN100357485C (en) * 2005-06-03 2007-12-26 四川大学 Method for post treatment of plasma spraying hydroxyapatite coating
JP6752724B2 (en) * 2014-03-03 2020-09-09 バイオウェイ サイエンティフィック エルエルシー Spherical porous hydroxyapatite adsorbent and its method
CN105185975B (en) * 2015-07-20 2017-07-18 合肥国轩高科动力能源有限公司 Preparation method of hydroxyapatite-coated lithium titanate
US20170056304A1 (en) * 2015-08-26 2017-03-02 Honeywell International Inc. Particulate hydroxyapatite compositions and methods for preparing the same

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007084858A2 (en) * 2006-01-12 2007-07-26 Rutgers, The State University Biomimetic hydroxyapatite synthesis
CN1903706A (en) * 2006-08-09 2007-01-31 山东大学 Preparation method of hydroxy phosephorite hollow microball
WO2010055231A2 (en) * 2008-11-13 2010-05-20 Universite De Reims Champagne-Ardenne Process for the electrodeposition of calcium-phosphorus coatings onto metallic substrates, coatings obtained and implantable materials comprising such coatings
CN101643929A (en) * 2009-08-31 2010-02-10 郑州大学 Pulse electrodeposition preparation method of hydroxyapatite coating on surface of pure magnesium or magnesium alloy
CN102061499A (en) * 2010-12-02 2011-05-18 上海师范大学 Method for preparing multihole hydroxyapatite/polyurethane composite material by electrochemical deposition
CN102908669A (en) * 2012-09-17 2013-02-06 西北工业大学 Preparation method of carbon foam/hydroxyapatite composite coating
CN108969802A (en) * 2018-07-19 2018-12-11 浙江大学 A kind of double induction hydroxyapatite silk fibroin composite membrane coating preparation methods with rush osteogenesis function
CN112121227A (en) * 2020-08-15 2020-12-25 吉林大学 Preparation method of medical composite coating of strontium titanate/strontium hydroxyapatite on titanium metal surface

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Structural changes of hydroxyapatite coating electrophoretically deposited on NiTi shape memory alloy;Karolina Dudek et al;《Ceramics International》;20180320;第44卷(第10期);第11292-11300页 *
羟基磷灰石粉体及涂层的制备与性能研究;杨梅;《中国优秀硕士学位论文全文数据库 工程科技Ⅰ辑》;20090415(第04期);第4,16-17,19,34,36-38页 *

Also Published As

Publication number Publication date
CN112875665A (en) 2021-06-01

Similar Documents

Publication Publication Date Title
CN112875665B (en) Hydroxyapatite microspheres for injection filling preparation and preparation method thereof
Molino et al. Biomimetic and mesoporous nano-hydroxyapatite for bone tissue application: A short review
US20070259181A1 (en) Ceramic Particle Group and Method for Production Thereof and Use Thereof
CN104548213B (en) Porous spherical calcium phosphate filling material and preparing method thereof
CN1217856C (en) Nanometer hydroxyapatite powder preparation method
CN106115642B (en) A kind of large scale hydroxyapatite porous microsphere material and preparation method thereof
CN103071447B (en) Method for preparing strontium-doped hydroxyapatite through supersound
Pham Minh et al. One-step synthesis of calcium hydroxyapatite from calcium carbonate and orthophosphoric acid under moderate conditions
CN106006593B (en) A kind of nano-calcium phosphate preparation method of simple and effective
CN103110952A (en) Microwave-assisted preparation method of hydroxylapatite nanometer structure porous microspheres
CN105883742B (en) A kind of preparation method of nano-β-tricalcium phosphate
Brundavanam et al. Effect of dilute gelatine on the ultrasonic thermally assisted synthesis of nano hydroxyapatite
US11584648B2 (en) Method for preparing octacalcium phosphate and octacalcium phosphate prepared thereby
Duan et al. Synthesis of Ca–P nanoparticles and fabrication of Ca–P/PHBV nanocomposite microspheres for bone tissue engineering applications
CN102320586B (en) A kind of synthetic method of amorphous calcium phosphate
Latocha et al. Morphology‐controlled precipitation/remodeling of plate and rod‐shaped hydroxyapatite nanoparticles
CN106430137A (en) Preparation method of spherical nano hydroxyapatite particles
CN102730658A (en) Sea urchin-like hydroxyapatite microparticles, preparation method and application thereof
Kimura Synthesis of hydroxyapatite by interfacial reaction in a multiple emulsion
CN100398433C (en) A kind of preparation method of hydroxyapatite hollow microspheres
CN106046399A (en) Preparation method of surface-mineralized chitosan microsphere
CN107497375B (en) Calcium phosphate nanoparticles and ion-complementary peptide composite hydrogel and preparation method thereof
CN105018086A (en) Rare-earth-doped calcium phosphate fluorescent nanoparticles, and preparation method and application thereof
Singh et al. Novel morphologies of mesoporous hierarchically assembled nanostructured hydroxyapatite particles: influence of some synthesis conditions
CN116946993A (en) An injectable high-purity medical hydroxyapatite microsphere and its preparation method

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
TR01 Transfer of patent right

Effective date of registration: 20240115

Address after: Room 1012, No. 5, Yiyuan Road, Haizhu District, Guangzhou, Guangdong 510310

Patentee after: Guangdong Zhanmei Biopharmaceutical Technology Co.,Ltd.

Address before: 130000 No. 2699 Qianjin Street, Jilin, Changchun

Patentee before: Jilin University

TR01 Transfer of patent right